Ionis Pharmaceuticals, Inc. Discontinued Operation, Tax Effect of Discontinued Operation
Ionis Pharmaceuticals, Inc. (IONS) reported Discontinued Operation, Tax Effect of Discontinued Operation of $16.80 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2012-02-29
- Ionis Pharmaceuticals, Inc. discontinued operation, tax effect of discontinued operation for fiscal 2009 was $16.80M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 12 month |
|---|---|
| 2009-12-31 | $16.80M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |